These epigenetic clocks represent a biochemical measure of biological age, quantifying the cumulative impact of time and environmental factors on the human genome. They specifically analyze DNA methylation patterns at precise CpG sites across the genome, offering a metric that often deviates from chronological age. This clinical tool provides critical insight into an individual’s intrinsic aging rate and the potential for longevity interventions.
Origin
The concept of an “epigenetic clock” emerged from the field of epigenetics and was pioneered by researchers like Steve Horvath in the early 2010s. It stems from the observation that specific methylation changes are highly correlated with chronological age across diverse human tissues and cell types. The term reflects the utility of these methylation markers as a reliable, quantifiable timer for the aging process.
Mechanism
The mechanism relies on DNA methyltransferases adding a methyl group to cytosine bases preceding a guanine nucleotide, known as a CpG site. With advancing biological age, certain CpG sites consistently gain methylation while others lose it, following a predictable trajectory. The resulting methylation profile is processed via an algorithm to yield a highly accurate estimate of biological age, serving as a dynamic biomarker for physiological decline and health span.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.